New benchmark: 1 kg of plasmid DNA manufactured

Roche’s Genen­tech unit will cut 3% of work­ers, a spokesper­son told End­points News Wednes­day, mak­ing it the lat­est drug­mak­er to an­nounce staffing re­duc­tions in re­cent

The FDA has lift­ed a par­tial clin­i­cal hold on In­nate Phar­ma’s IND for its po­ten­tial can­cer drug la­cu­tam­ab af­ter it first im­posed the hold in

CVS Health an­nounced Wednes­day that it launched a busi­ness that will work with drug­mak­ers to com­mer­cial­ize and man­u­fac­ture biosim­i­lars in the US, start­ing with a